2025M&A Transaction Multiples
Pharmacy Multiples - 2025
Sourced from 11 publicly disclosed Pharmacy acquisitions in 2025. Public records only (SEC EDGAR + verified press releases).
EV / EBITDA
11.2x
median · p25 4.3x - p75 19.6x · n=8
EV / Revenue
0.3x
median · p25 0.1x - p75 1.2x · n=7
Value your Pharmacy business
Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.
Pharmacy multiples by year
Other verticals - 2025 multiples
Food Manufacturing· 7.4x EBITDAHealthcare IT· 26.55x EBITDAIndustrial Equipment· 11x EBITDAIT Services· 9.04x EBITDALaboratory Services· 13.8x EBITDAMedical Devices· 13.36x EBITDAMental Health· 8.6x EBITDAMetal Fabrication· 29.52x EBITDAOil Gas Services· 6.75x EBITDAOther· 15.16x EBITDAOther Healthcare· 16x EBITDAOther Manufacturing· 10.66x EBITDAOther Professional Services· 13.1x EBITDAOther Technology· 21.38x EBITDASaaS· 35.3x EBITDASpecialty Contractor· 9.19x EBITDAWholesale Distribution· 9.61x EBITDA
Data sourced from 11 disclosed Pharmacy M&A transactions in 2025. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →